Updates

Zydus Lifesciences Limited has announced disclosures under SEBI (Prohibition of Insider Trading) Regulations regarding its recent share buyback program. The announcement details the acceptance of equity shares tendered by promoters, promoter group, directors, and their immediate relatives through a proportionate tender offer. Notably, Zydus Family Trust, a key promoter, had 63,49,542 equity shares accepted in the buyback. Post-buyback, the Trust's holding percentage slightly increased from 74.96% to 74.98%. This signifies strong promoter participation and their continued significant stake in the company following the tender offer.